)
Tenon Medical (TNON) investor relations material
Tenon Medical Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Medical device company focused on minimally invasive sacroiliac (SI) joint fusion solutions for lower back pain, with FDA-cleared Catamaran SI Joint Fusion System and recent acquisition of SImmetry SI Joint Fusion System assets.
Targets three commercial opportunities: primary SI joint procedures, revision of failed implants, and SI joint fusion adjunct to spine fusion.
National commercial launch of Catamaran System began in October 2022, emphasizing a single-implant, less invasive approach with proprietary features.
Acquired assets from SiVantage, Inc. and SIMPL Medical, LLC in August 2025 to expand product offerings and market reach.
Market opportunity and competitive landscape
Over 30 million American adults suffer from chronic lower back pain; 15–30% is associated with the SI joint.
Surgical penetration for SI joint pain remains low (5–7%) due to complexity and suboptimal existing solutions, presenting significant growth potential.
Catamaran System aims to address limitations of current treatments with a direct, visualized, single-implant approach and radiographic confirmation of fusion.
Financial performance and metrics
Raised approximately $2.85 million in gross proceeds from a private placement in November 2025.
Common stock listed on Nasdaq Capital Market under symbol "TNON"; closing price was $1.11 per share on December 8, 2025.
- TimeTickerHeadlineOpen
- 9432
Revenue and profit rose, comprehensive income surged, and financial business expanded. - APTUS
AUM up 21% YoY, profit up 26%, strong asset quality, digital adoption, and capital adequacy. - JSWCEMENT
Q3 FY26 delivered 14% volume and 13% revenue growth, with EBITDA up 32% and PAT at ₹130.6 crore. - SAATVIKGL
Revenue and profit more than doubled YoY, with strong execution and capacity expansion. - 009830
FY2025 revenue rose, but operating losses widened amid persistent market and policy risks. - IKS
Q3 FY26 saw 24% revenue growth, 40%+ EBITDA growth, and strong cash generation. - CCL
Q3 delivered strong revenue and profit growth, lower debt, and an interim dividend of Rs. 2.75. - 500480
Record gross margins and strong distribution offset Power Gen and export softness; FY26 outlook robust. - HEXT
CY25 revenue up 7.6% YoY, strong AI launches, and CY26 growth expected to accelerate. - SHAK
Revenue up 16.5%, net income $10.4M, and 23 new Shacks opened, with margin expansion.
Next Tenon Medical earnings date
Next Tenon Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)